IVAX Pharmaceuticals, Inc. Shareholders Overwhelmingly Elect To Receive Stock Consideration In Teva Pharmaceutical Industries Limited Merger

Published: Jan 25, 2006

MIAMI--(BUSINESS WIRE)--Jan. 25, 2006--At the request of The American Stock Exchange, IVAX Corporation (AMEX:IVX) (LSE:IVX.L) (WSE:IVX) announced today that an overwhelming majority of shareholders who made their elections prior to yesterday's deadline for making a cash or stock election under the merger agreement elected to receive stock consideration (0.8471 of a Teva ADR for each share of IVAX common stock). As a result, all shareholders who failed to make an election will receive cash consideration ($26.00 for each share of IVAX common stock).

Back to news